FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2146602833> ?p ?o ?g. }

• W2146602833 endingPage "20" @default.
• W2146602833 startingPage "11" @default.
• W2146602833 abstract "Abstract A few tumor antigen (TA)–specific monoclonal antibodies (mAb) have been approved by the Food and Drug Administration for the treatment of several major malignant diseases and are commercially available. Once in the clinic, mAbs have an average success rate of ∼30% and are well tolerated. These results have changed the face of cancer therapy, bringing us closer to more specific and more effective biological therapy of cancer. The challenge facing tumor immunologists at present is represented by the identification of the mechanism(s) underlying the patients' differential clinical response to mAb-based immunotherapy. This information is expected to lead to the development of criteria to select patients to be treated with mAb-based immunotherapy. In the past, in vitro and in vivo evidence has shown that TA-specific mAbs can mediate their therapeutic effect by inducing tumor cell apoptosis, inhibiting the targeted antigen function, blocking tumor cell signaling, and/or mediating complement- or cell-dependent lysis of tumor cells. More recent evidence suggests that TA-specific mAb can induce TA-specific cytotoxic T-cell responses by enhancing TA uptake by dendritic cells and cross-priming of T cells. In this review, we briefly summarize the TA-specific mAbs that have received Food and Drug Administration approval. Next, we review the potential mechanisms underlying the therapeutic efficacy of TA-specific mAbs with emphasis on the induction of TA-specific cellular immune responses and their potential to contribute to the clinical efficacy of TA-specific mAb-based immunotherapy. Lastly, we discuss the potential negative effect of immune escape mechanisms on the clinical efficacy of TA-specific mAb-based immunotherapy. Clin Cancer Res; 16(1); 11–20" @default.
• W2146602833 created "2016-06-24" @default.
• W2146602833 creator A5032986788 @default.
• W2146602833 creator A5064249197 @default.
• W2146602833 creator A5077760288 @default.
• W2146602833 creator A5086074491 @default.
• W2146602833 date "2010-01-01" @default.
• W2146602833 modified "2023-10-01" @default.
• W2146602833 title "Immunotherapy of Malignant Disease with Tumor Antigen–Specific Monoclonal Antibodies" @default.
• W2146602833 cites W1485219489 @default.
• W2146602833 cites W1547364212 @default.
• W2146602833 cites W1922507831 @default.
• W2146602833 cites W1965213354 @default.
• W2146602833 cites W1970313991 @default.
• W2146602833 cites W1973917219 @default.
• W2146602833 cites W1981531780 @default.
• W2146602833 cites W1982626297 @default.
• W2146602833 cites W2009218955 @default.
• W2146602833 cites W2009512645 @default.
• W2146602833 cites W2010690729 @default.
• W2146602833 cites W2012629036 @default.
• W2146602833 cites W2023270917 @default.
• W2146602833 cites W2024896474 @default.
• W2146602833 cites W2027732045 @default.
• W2146602833 cites W2030177319 @default.
• W2146602833 cites W2030229022 @default.
• W2146602833 cites W2030522563 @default.
• W2146602833 cites W2035433348 @default.
• W2146602833 cites W2039633811 @default.
• W2146602833 cites W2048380366 @default.
• W2146602833 cites W2048599407 @default.
• W2146602833 cites W2050105922 @default.
• W2146602833 cites W2050243165 @default.
• W2146602833 cites W2064766870 @default.
• W2146602833 cites W2065927659 @default.
• W2146602833 cites W2068125497 @default.
• W2146602833 cites W2068635250 @default.
• W2146602833 cites W2069524809 @default.
• W2146602833 cites W2076424556 @default.
• W2146602833 cites W2081717004 @default.
• W2146602833 cites W2083982805 @default.
• W2146602833 cites W2084185832 @default.
• W2146602833 cites W2090789725 @default.
• W2146602833 cites W2093334570 @default.
• W2146602833 cites W2094241271 @default.
• W2146602833 cites W2094618776 @default.
• W2146602833 cites W2097199873 @default.
• W2146602833 cites W2103118255 @default.
• W2146602833 cites W2110233014 @default.
• W2146602833 cites W2111555376 @default.
• W2146602833 cites W2124749346 @default.
• W2146602833 cites W2133105825 @default.
• W2146602833 cites W2140177945 @default.
• W2146602833 cites W2146220880 @default.
• W2146602833 cites W2155917684 @default.
• W2146602833 cites W2168109319 @default.
• W2146602833 cites W2168648203 @default.
• W2146602833 cites W2316091998 @default.
• W2146602833 cites W254201 @default.
• W2146602833 cites W3000054250 @default.
• W2146602833 cites W4242069792 @default.
• W2146602833 cites W4242972998 @default.
• W2146602833 cites W4254635893 @default.
• W2146602833 doi "https://doi.org/10.1158/1078-0432.ccr-09-2345" @default.
• W2146602833 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2802861" @default.
• W2146602833 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20028761" @default.
• W2146602833 hasPublicationYear "2010" @default.
• W2146602833 type Work @default.
• W2146602833 sameAs 2146602833 @default.
• W2146602833 citedByCount "65" @default.
• W2146602833 countsByYear W21466028332012 @default.
• W2146602833 countsByYear W21466028332013 @default.
• W2146602833 countsByYear W21466028332014 @default.
• W2146602833 countsByYear W21466028332015 @default.
• W2146602833 countsByYear W21466028332016 @default.
• W2146602833 countsByYear W21466028332017 @default.
• W2146602833 countsByYear W21466028332019 @default.
• W2146602833 countsByYear W21466028332020 @default.
• W2146602833 countsByYear W21466028332021 @default.
• W2146602833 countsByYear W21466028332022 @default.
• W2146602833 crossrefType "journal-article" @default.
• W2146602833 hasAuthorship W2146602833A5032986788 @default.
• W2146602833 hasAuthorship W2146602833A5064249197 @default.
• W2146602833 hasAuthorship W2146602833A5077760288 @default.
• W2146602833 hasAuthorship W2146602833A5086074491 @default.
• W2146602833 hasBestOaLocation W21466028331 @default.
• W2146602833 hasConcept C100701293 @default.
• W2146602833 hasConcept C121608353 @default.
• W2146602833 hasConcept C126322002 @default.
• W2146602833 hasConcept C147483822 @default.
• W2146602833 hasConcept C154317977 @default.
• W2146602833 hasConcept C159654299 @default.
• W2146602833 hasConcept C202751555 @default.
• W2146602833 hasConcept C203014093 @default.
• W2146602833 hasConcept C2776662205 @default.
• W2146602833 hasConcept C2777701055 @default.
• W2146602833 hasConcept C2780674031 @default.
• W2146602833 hasConcept C502942594 @default.

• next